Andrea J Darzi
Overview
Explore the profile of Andrea J Darzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
658
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Alba A, Darzi A, Buchan T, Kum E, Uhlman K, Aleksova N, et al.
J Clin Epidemiol
. 2023 Oct;
164:15-26.
PMID: 37852391
Objectives: Studies evaluating the effectiveness of care based on patients' risk of adverse outcomes (risk-guided care) use a variety of study designs. In this scoping review, using examples, we review...
12.
Dewidar O, Bondok M, Abdelrazeq L, Aliyeva K, Solo K, Welch V, et al.
J Clin Epidemiol
. 2023 Aug;
161:116-126.
PMID: 37562727
Background And Objective: To identify COVID-19 actionable statements (e.g., recommendations) focused on specific disadvantaged populations in the living map of COVID-19 recommendations (eCOVIDRecMap) and describe how health equity was assessed...
13.
Morsi R, Zhang Y, Carrion-Penagos J, Desai H, Tannous E, Kothari S, et al.
BMJ Open
. 2023 Jun;
13(6):e064322.
PMID: 37308271
Introduction: Current published guidelines and meta-analyses comparing endovascular thrombectomy (EVT) alone versus EVT with bridging intravenous thrombolysis (IVT) suggest that EVT alone is non-inferior to EVT with bridging thrombolysis in...
14.
Darzi A, Busse J, Phillips M, Wykoff C, Guymer R, Thabane L, et al.
Eye (Lond)
. 2023 Feb;
37(15):3055-3058.
PMID: 36854816
No abstract available.
15.
Cuker A, Tseng E, Schunemann H, Angchaisuksiri P, Blair C, Dane K, et al.
Blood Adv
. 2022 Jun;
6(17):4975-4982.
PMID: 35748885
Background: COVID-19-related critical illness is associated with an increased risk of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients,...
16.
Karam S, Darzi A, Bognanni A, Morsi R, Tannous E, Charide R, et al.
J Clin Epidemiol
. 2022 Jun;
149:206-216.
PMID: 35724863
Objectives: Analytical frameworks are graphical representation of the key questions answered by a systematic review and can support the development of guideline recommendations. Our objectives were to a) conduct a...
17.
Cuker A, Tseng E, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, et al.
Blood Adv
. 2022 May;
6(17):4915-4923.
PMID: 35503027
Background: COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE). Objective: These evidence-based guidelines from the American Society of Hematology (ASH) are intended to support patients,...
18.
Morgano G, Mbuagbaw L, Santesso N, Xie F, Brozek J, Siebert U, et al.
BMJ Open
. 2022 Mar;
12(3):e053246.
PMID: 35273045
Introduction: The Grading of Recommendations Assessment, Development and Evaluation (GRADE) and similar Evidence to Decision (EtD) frameworks require its users to judge how substantial the effects of interventions are on...
19.
Darzi A, Busse J, Phillips M, Singh R, Holz F, Thabane L, et al.
Eye (Lond)
. 2022 Jan;
36(6):1135-1137.
PMID: 35067683
No abstract available.
20.
Cuker A, Tseng E, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, et al.
Blood Adv
. 2021 Nov;
6(2):664-671.
PMID: 34727173
Background: COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients,...